Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Its not just that AOD9604 is hard to make (although it is), but also that its a very specific modified fragment
A common titration approach includes: Week 12: 0.3 mg Week 34: 0.6 mg Week 56: 1.2 mg Week 78: 1.8 mg Week 9 and onward: 2.4 mg or higher, based on tolerance and clinical response Always consult a healthcare provider or licensed research facility for actual dosing guidance
The Reuters report on a head-to-head trial against tirzepatide (February 2026) noted CagriSema did not meet a non-inferiority threshold against tirzepatide on average weight loss at 84 weeks
Conclusions: Cere treatment was well tolerated and resulted in significant improvements in the global score two months after the end of active treatment
Safety and proof of effect rely on objective tracking
US$ 26.45
US$ 28.29
US$ 24.39
US$ 21.62
US$ 25.94
US$ 26.29
US$ 24.96
